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The packaging of a mature dimeric RNA genome is an essential step in human immunodeficiency virus type
1 (HIV-1) replication. We have previously shown that overexpression of a protease (PR)-inactive HIV-1
Gag-Pro-Pol precursor protein generates noninfectious virions that contain mainly monomeric RNA (M.
Shehu-Xhilaga, S. M. Crowe, and J. Mak, J. Virol. 75:1834–1841, 2001). To further define the contribution of
HIV-1 Gag and Gag-Pro-Pol to RNA maturation, we analyzed virion RNA dimers derived from Gag particles
in the absence of Gag-Pro-Pol. Compared to wild-type (WT) dimeric RNAs, these RNA dimers have altered
mobility and low stability under electrophoresis conditions, suggesting that the HIV-1 Gag precursor protein
alone is not sufficient to stabilize the dimeric virion RNA structure. The inclusion of an active viral PR, without
reverse transcriptase (RT) and integrase (IN), rescued the stability of the virion RNA dimers in the Gag
particles but did not restore the mobility of the RNAs, suggesting that RT and IN are also required for virion
RNA dimer maturation. Thin-section electron microscopy showed that viral particles deficient in RT and IN
contain empty cone-shaped cores. The abnormal core structure indicates a requirement for Gag-Pro-Pol
packaging during core maturation. Supplementing viral particles with either RT or IN via Vpr-RT or Vpr-IN
alone did not correct the conformation of the dimer RNAs, whereas expression of both RT and IN in trans as
a Vpr-RT-IN fusion restored RNA dimer conformation to that of the WT virus and also restored the electron-
dense, cone-shaped virion core characteristic of WT virus. Our data suggest a role for RT-IN in RNA dimer
conformation and the formation of the electron-dense viral core.
The gag and pol genes of human immunodeficiency virus
type 1 (HIV-1) are initially expressed as the precursor polypro-
teins Gag and Gag-Pro-Pol (8, 41). During or immediately
after budding these precursors are processed by the viral pro-
tease (PR) into their mature products (8). The 55-kDa Gag
precursor generates matrix (MA), capsid (CA), spacer peptide
p2, nucleocapsid (NC), spacer peptide p1, and p6gag. The 160-
kDa Gag-Pro-Pol fusion protein generates MA, CA, p2, NC,
p6pol, PR, reverse transcriptase (RT), and integrase (IN) (19).
The Gag and Gag-Pro-Pol polyproteins are encoded by the
same mRNA but are not synthesized at the same rate. An
infrequent ribosomal frameshifting event generates a 20:1 ratio
of Gag to Gag-Pro-Pol production. In HIV-1, the maintenance
of this ratio is critical for viral infectivity and genomic RNA
dimer stability (38).
Intracellular expression of Gag alone is sufficient to produce
virion-like particles (VLPs) (for a review, see reference 43).
Moreover, there is an important role for Gag and viral
genomic RNA interactions in the assembly process, with the
packaging and dimerization of the genomic RNA primarily
occurring via RNA-Gag interactions (2, 10, 29). The NC do-
main of Gag binds to viral RNA and has been shown to facil-
itate both the RNA packaging and the dimerization processes
(3, 4, 7, 9, 17). The initial interaction between genomic RNA
and HIV-1 Gag is likely to occur via the NC sequences within
the Gag precursor, as HIV-1 with defective viral PR still pack-
ages RNA (for a review see reference 12). Furthermore, anal-
ysis of wild-type (WT) and PR-defective (PR) virions has
revealed that dimerization of the genomic RNA in HIV-1
initiates prior to proteolytic processing (13), suggesting that
Gag and Gag-Pro-Pol precursor proteins can support RNA
dimerization independently of protein processing. However, to
date, RNA dimer formation and the stability of genomic RNA
in Gag-only particles and the contribution of Gag-Pro-Pol to
dimer formation have not been well defined.
Morphological studies of HIV-1 particles have shown that
infectious virions are characterized by a condensed, cone-
shaped core structure surrounding the genomic RNA, which is
thought to bind to NC, RT, and IN (8). Incorporation of
Gag-Pro-Pol is critical for viral assembly, supplying the viral
enzymes and mediating the selective packaging of the primer
tRNA (22, 30, 32). In addition, DNA synthesis by an RT-
defective virus cannot be rescued by exogenously supplied RT,
suggesting that the Gag-Pro-Pol precursor is necessary to
maintain RT in proper association with the ribonucleoprotein
initiation complex (1). However, our understanding of the role
of the precursor Gag-Pro-Pol in genomic RNA dimer forma-
tion and maturation is limited. The packaging of the retrovirus
enzymes in the form of a precursor protein is in itself sugges-
tive of a role for Gag-Pro-Pol in coordinating the placement of
the viral enzymes within the mature virion and supporting the
correct molecular arrangements for Gag-RNA interactions.
Functional RT and IN proteins can be incorporated into viral
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particles when supplied in trans as Vpr fusion proteins to
generate infectious virions (28, 45). Such an approach provides
a powerful tool for investigating the role of IN and RT in viral
genomic RNA dimerization outside the context of the Gag-
Pro-Pol protein.
We have taken advantage of the supplementation approach
described by Wu et al. (45) to investigate the role of Gag and
Gag-Pro-Pol and its component enzymes in RNA dimeri-
zation. Isolation and analysis of viral genomic RNA from
Gag-derived particles (GUAA) has facilitated studies of the
conformation of genomic RNA dimers in the absence of
the Pol-derived proteins. The inclusion of an active PR in the
GUAA construct (PRUAA) provides a means to examine the
role of Gag proteolysis in genomic RNA dimerization. Supple-
mentation of RT and IN in trans, as a Vpr-RT, Vpr-IN, or
Vpr-RT-IN fusion protein, enables an assessment of the role of
these enzymes in viral assembly and RNA dimer maturation
that is independent of the Gag-Pro-Pol precursor protein.
We show here that the HIV-1 Gag alone does not generate
stable dimeric RNA in the correct conformation. While the
stability of the genomic RNA isolated from these virus-like
particles (VLPs) is reestablished by Gag proteolysis, the con-
formation of the RNA dimers is only partially restored. In
addition, thin-section electron microscopy (TSEM) demon-
strates that processing of Gag leads to the formation of cone-
shaped, electron-lucent cores. Although independent packag-
ing of Vpr-RT and Vpr-IN into processed Gag particles is not
sufficient for RNA dimer maturation, virion packaging of the
Vpr-RT-IN fusion protein restores the RNA dimer conforma-
tion and leads to the formation of an electron-dense, cone-
shaped core similar to that observed in the WT particles.
MATERIALS AND METHODS
DNA plasmids. The WT HIV-1 plasmid used in this study, HXB2-BH10, has
been previously described (42). PR-defective HIV-1 plasmid SVC21 PR(-),
which has also been described previously (18, 30), was utilized as a control. The
Gag frame (GF) mutant was constructed to reduce the level of Gag-Pro-Pol
synthesis in the virus-producing cells. This mutation involves substitutions in the
five-T stretch of nucleotides, which are responsible for the 1 ribosomal frame-
shifting, thus making it difficult for the ribosome to shift back and synthesize
Gag-Pro-Pol. The tttttta sequence responsible for frameshifting was replaced
with the cttcctt sequence by PCR stitch mutagenesis. Briefly, primers f1-sense
(5ggcaaagaagggcacacagcc 3) and f1-antisense (5cccgaggaagttagcctgtctctcagtac
3) were used to amplify a 130-bp GF f1 fragment. Primers f2-sense (5ggctaac
ttcctcgggaagatctggccttcc 3) and f2-antisense (5gttgacaggtgtaggtcctac 3) were
used to amplify a 400-bp GF f2 fragment. The GF f1 and GF f2 fragments were
joined by PCR extension. The resulting PCR-amplified fragment was cloned into
the HxB2-BH10 proviral DNA via restriction sites ApaI and BclI. To obtain the
PR-defective form of GF [GF PR(-)], the aspartic acid at the active site of PR of
the GF construct was replaced with asparagine via PCR stitch mutagenesis. The
GUAA plasmid was constructed by PCR stitch mutagenesis to introduce a stop
codon at amino acid position 13 of PR. As a result, this mutation does not allow
the synthesis of full-length Gag-Pro-Pol or the expression of a functional PR. The
PRUAA mutant was constructed to produce HIV-1 Gag particles that are cleaved
by PR in the absence of RT and IN. Briefly, PCR stitch mutagenesis was used to
introduce a stop codon within the Pol frame straight after the region encoding
PR, allowing PR expression. The introduced mutations were confirmed by DNA
sequencing. The Vpr-RT, Vpr-IN, and Vpr-RT-IN expression plasmids have
been previously described (45).
Virus production. The production of WT and mutant viral particles was
achieved by the transfection of 10 g of proviral DNA into 293T cells by a
calcium phosphate method as previously described (24). For the supplementa-
tion studies 10 g of Vpr-RT, Vpr-IN, or Vpr-RT-IN expression plasmid DNA
was used in cotransfection with 10 g of the PRUAA plasmid to generate viral
particles that contain RT, IN, or RT-IN. An enhanced green fluorescent protein
(EGFP; Clontech, Palo Alto, Calif.) reporter plasmid (2 g) was added to the
DNA mixture to determine transfection efficiency.
Supernatants were collected 36 h posttransfection and centrifuged for 30 min
at 2,000  g and 4°C to remove cellular debris. The clarified supernatants were
either frozen at 70°C or used immediately for further analysis. Cells were
washed twice with either 1 phosphate-buffered saline (PBS) or 1 Tris-buff-
ered saline (TBS buffer; 50 mM Tris [pH 7.4], 150 mM NaCl), followed by
protein extraction using lysis buffer containing 1 TBS, 10 l of Nonidet P-40/
ml, 20 mM phenylmethylsulfonyl fluoride, 1 M pepstatin, and 1 M leupeptin.
Cell lysates were collected and stored at 20°C for later use.
Intracellular viral protein analysis. Cell lysates were rapidly frozen and
thawed three times to weaken the cellular membrane. Cell debris was subse-
quently removed by centrifugation for 30 min at 4°C and 2,000  g. The trans-
fection efficiency of the samples was determined by measuring the level of EGFP
from the reporter plasmid with a Bio Imaging Analyzer (Fuji Photo Film Co.).
Cellular proteins from each sample, normalized for equivalent levels of EGFP,
were mixed with 3 l of sample buffer (100 mM Tris [pH 6.8], 3% sodium
dodecyl sulfate [SDS], 33% glycerol, 0.03% bromophenol blue), heat-denatured
for 10 min at 95°C, and resolved by 10% Tris-glycine SDS–polyacrylamide gel
electrophoresis (PAGE). Resolved proteins were transferred to a nitrocellulose
membrane (Amersham). The membrane was blocked for 2 h in 3% casein
dissolved in 2 TBS containing 0.3% Tween 20 (TBST) and probed overnight
with pooled HIV-1-seropositive patient sera or an anti-p24 monoclonal antibody
(NEN). After three washes with 1 TBST buffer the membrane was incubated
with a horseradish peroxidase-conjugated antihuman secondary antibody
(DAKO) for 2 h at room temperature. An enhanced chemiluminescence tech-
nique was used for visualization of HIV-1 proteins present in the cellular lysates
(Amersham). Chemiluminescence was recorded by autoradiography.
Virion purification and protein analysis. Supernatants from transfected cells
were first clarified from cell debris by centrifugation for 30 min at 4°C and 2,000
 g. Viral particles were concentrated by ultracentrifugation through a 20%
sucrose cushion using a Beckman ultracentrifuge (model L-90; SW 41 rotor) at
150,000  g for 1 h at 4°C. Pellets were resuspended in 50 l of TBS lysis buffer.
Levels of virion proteins were first estimated via serial dilutions of virion proteins
in Western dot blot analysis. HIV-1-positive patient serum was used as the
primary antibody, followed by a horseradish peroxidase-conjugated antihuman
secondary antibody. Enhanced chemiluminescence was then used for the quan-
tification of total virion proteins. Equal amounts of virion proteins from each
sample were mixed with 3 l of sample buffer containing 5 mM -mercapto-
ethanol, and the mixture was heated for 10 min at 95°C. Virion proteins were
then resolved by 10% Tris-glycine SDS-PAGE as described above. The resolved
virion protein samples were transferred onto nitrocellulose membranes by elec-
trophoresis using a Bio-Rad transfer apparatus. Virion HIV-1 protein profiles of
the samples were determined by Western analysis as described above.
Analysis of virion RNA packaging. Pelleted virions were prepared by ultra-
centrifugation as described above and were resuspended in 500 l of Trizol
(Gibco) for genomic RNA extraction. Samples were subsequently incubated for
30 min in ice to allow complete lysis to occur, and 200 l of chloroform was
added to remove the organic solvent and virion proteins. Samples were mixed
and centrifuged for 20 min at 20,000 g at 4°C. The aqueous layer containing the
RNA was transferred to a fresh Eppendorf tube and precipitated with 1/10
volume of 3 M sodium acetate–1 ml of ice-cold 100% ethanol at 20°C over-
night. Precipitated RNA samples were centrifuged for 30 min at 20,000  g and
4°C. The RNA pellets were washed with 200 l of 70% ethanol and then air dried
for 1 h at room temperature. Each pellet was resuspended in 10 l of RNase-free
water and stored at 20°C until use.
Genomic packaging of virion RNA was assessed by RNA dot blotting using a
Bio-Rad dot blot apparatus. Serial 10-fold dilutions of virion RNA samples,
which were normalized by total virion protein, were used to construct a standard
curve. Each sample was mixed with 29 l of RNA denaturation buffer (37%
formaldehyde, 60% deionized formamide, 3% 20 SSC [3 M NaCl, 0.3 M
sodium citrate, pH 7.0]) and incubated at 65°C for 10 min for RNA denaturation.
After incubation, samples were immediately chilled on ice. To each tube, 78 l
of 20 SSC buffer was added, and samples were loaded onto a Hybond mem-
brane (Amersham) via a dot blot apparatus (Bio-Rad). The wells were washed
twice with 10 SSC, and the membrane was air dried overnight at room tem-
perature. The membrane was exposed to UV light for 90 s to cross-link the RNA
onto the membrane and then blocked for 1 h at 42°C with 10 ml of hybridization
buffer (40 ml of the hybridization buffer contains 8 ml of 5 SSPE [750 mM
NaCl, 63 mM NaH2PO4, 0.5 mM EDTA], 20 ml of deionized formamide, 4 g of
dextran sulfate, 400 l of salmon sperm DNA [10 mg/ml], 3 ml of 20% SDS, and
5 ml of double-distilled H2O).
The amount of genomic RNA in the viral RNA samples was quantified by
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using radioactive antisense oligonucleotide probe 790H (5CTGACGCTCTCG
CACCC3), which has been previously described (31). Briefly, the 790H oli-
gomer binds specifically to the HIV-1 genomic RNA sequence between positions
338 and 354 (DNA positions 791 to 807). The 790H oligomer was 5 end labeled
with T4 polynucleotide kinase and -32P-labeled ATP (3,000 Ci/mmol; Amer-
sham). The membrane containing the RNA samples was incubated overnight at
42°C with the radioactively labeled probe. The membrane was washed once for
30 min with 1 SSC–0.1% SDS and twice with 0.2 SSC–0.1 SDS for 30 min.
The results were visualized by autoradiography.
Analysis of virion RNA dimerization. Virion pellets were resuspended in 500
l of dimeric RNA lysis buffer (10 mM Tris [pH 7.5], 1 mM EDTA, 1% SDS, 50
mM NaCl, 10 U of proteinase K), extracted with phenol-chloroform, and isolated
for melting curve analysis as previously described (13, 14).
Similar amounts of genomic RNA were used to analyze the stability of the
virion RNA dimer in each preparation. Samples were heated at various temper-
atures (indicated at the bottom of each gel) for a period of 10 min, followed by
a quick chill on ice. Heat-denatured dimeric and monomeric RNAs were sepa-
rated by electrophoresis in a 1% native agarose gel in 0.5 Tris-borate-EDTA
buffer. Samples were transferred overnight onto a nitrocellulose (Hybond N)
membrane (Amersham). The membrane containing the RNA samples was air
dried for 2 h at room temperature and exposed to UV light for 90 s for cross-
linking. The membrane was blocked for 1 h at 42°C with 10 ml of hybridization
buffer and incubated overnight with a radioactive riboprobe (pGEM7zHIV-1),
which is complementary to the 5 end of the HIV-1 genomic RNA sequences, as
previously described (38). The radioactive riboprobe was synthesized by linear-
izing pGEM7z HIV-1 with BamHI, followed by T7 RNA polymerase-directed in
vitro transcription (Promega) in the presence of [-32P]CTP (NEN). After being
probed, the membrane was washed once for 30 min with 1 SSC–0.1% SDS
buffer and twice for 30 min with 0.2 SSC–0.1% SDS buffer. The results were
visualized by autoradiography.
Metabolic labeling of virion proteins. 293T cells were transfected with 10 g
of each plasmid DNA by the calcium phosphate method described above. Twelve
hours posttransfection cells were washed twice with PBS and incubated for an
additional 12 h in fresh media. Subsequently, cells were washed with PBS and
starved for 1 h in methionine- and cysteine-free Dulbecco’s modified Eagle
medium containing 10% dialyzed fetal calf serum (FCS) (ICN Biochemicals).
Cells were washed twice with PBS and cultured in methionine- and cysteine-free
medium containing [35S]methionine-cysteine (70 mCi/ml; specific activity, 1,175
Ci/mmol; ICN Biochemicals). After a 1-h incubation at 37°C, 10% FCS was
replenished and virus production was monitored every 6 h by measuring RT
levels. To determine the RT levels for each virus, 10 l of supernatant from each
sample was mixed with 10 l of NP-40. Samples were incubated for 30 min at
room temperature for inactivation of the virus, and the RT activities of the
viruses in the supernatant were measured by a micro-RT assay as previously
described (15).
Labeled virus, isolated 36 h posttransfection, was first clarified from cell debris
at 3,000 rpm for 30 min at 4°C in a Beckman centrifuge and pelleted through a
20% sucrose cushion with a Beckman model L-90 ultracentrifuge (SW 41 rotor).
Standardized amounts of HIV proteins and genomic RNA extracted from la-
beled, pelleted WT and mutant viruses were loaded onto a nitrocellulose (Hy-
bond N) membrane (Amersham) for the detection of 35S-labeled proteins. The
specific activity of the [35S]methionine-cysteine labeling was 124,800 cpm/g of
labeled HIV-1 proteins. The presence of the 35S-labeled proteins was monitored
by phosphorimaging (Fuji Photo Film Co.), which has a detection limit of the
equivalent of 1 ng of our labeled protein.
TSEM. Transfected 293T cells were harvested 36 h posttransfection and pro-
cessed for TSEM essentially as described previously (27). Briefly, cells were
washed in cacodylate (CAC) buffer (pH 7.3) and pelleted by centrifugation at 500
 g for 5 min. The cell pellet was then fixed in 2% (wt/vol) glutaraldehyde-CAC
buffer for 1 h at 4°C. After several washes in CAC buffer, the pellet underwent
secondary fixation in 1% (wt/vol) osmium tetroxide-CAC buffer for 1 h at 4°C.
Pellets were rinsed in distilled water, dehydrated in graded ethanols, cleared in
propylene oxide, and embedded in Spurr resin (Ladd Research, Inc., Williston,
Vt.). Ultrathin sections with silver and gold interference colors were mounted on
uncoated 200-mesh copper grids and stained with uranyl acetate and lead citrate.
The sections were then examined with a CM12 electron microscope (Philips).
RESULTS
Reduction in synthesis of the Gag-Pro-Pol protein is asso-
ciated with a decrease in p24-CA. 293T cells were transfected
with the WT control, HXB2-BH10, or mutants derived from
this infectious clone, namely GF, GF PR(-), and GUAA, and a
PR control (Fig. 1). The PR control showed no proteolytic
processing of Gag and Gag-Pro-Pol polyproteins due to inac-
tivation of viral PR (Fig. 2i, virion, lane 2). Mutants GF, GF
PR(-), and GUAA each restrict Pol protein synthesis. Assess-
ment by Western blot analysis showed intracellular protein
profiles that were consistent with the introduced mutations
(Fig. 2i, cell). Restricting the synthesis of Pol proteins resulted
in a corresponding decrease of p24-CA in VLPs (Fig. 2i, viri-
on). The GF construct, which contains a mutation that alters
the frameshifting site within the HIV-1 genome, generated a
2.5-fold decrease in p24-CA in VLPs compared to the level in
WT virions as determined by phosphorimaging (data not
shown), demonstrating that this mutation hinders but does not
abolish Gag-Pro-Pol synthesis (Fig. 2i, virion, lane 3). The GF
PR(-) construct produced no p24-CA due to the mutation of
the PR active site within the GF. As the GUAA construct did
not support Gag-Pro-Pol synthesis, both cellular and virion
protein profiles showed only Gag (Fig. 2i, cell and virion, lane
5, respectively).
Genomic RNAs isolated from Gag-derived particles display
altered mobility in comparison to mature WT genomic RNA
dimers and immature PR RNA dimers. The WT genomic
virion RNA migrated as sharp dimeric RNA and started dis-
FIG. 1. Schematic representation of proviral DNA constructs used
in the study. The WT plasmid is HxB2-BH10 and has been previously
described (42). A PCR-amplified fragment was cloned into the HxB2-
BH10 proviral DNA via restriction sites ApaI and BclI to alter 1
ribosomal frameshifting (GF). To obtain the GF PR(-) mutant, the
aspartic acid at the active site of PR of the GF construct was replaced
with asparagine via PCR mutagenesis. A stop codon introduced within
the frame of the Pol protein terminated Gag-Pro-Pol synthesis in
amino acid 13 of PR (GUAA) and abolished PR activity.
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FIG. 2. The impact of mutations within the Gag and Gag-Pro-Pol regions of HIV-1 on the protein compositions of purified virions and genomic
RNA dimer maturation. (i) Viral proteins were semiquantified by Western blot analysis. Purified virions were resolved by 10% Tris-glycine
SDS-PAGE. Resolved proteins were probed with pooled sera from HIV-1-infected individuals as described in Materials and Methods. (ii) The
impact of mutations within the Gag-Pro-Pol region in RNA dimer formation and stability was determined by using a melting curve combined with
electrophoretic analysis of WT and mutant dimers. Virion RNA was resuspended in RNA dimerization buffer and heat denatured for 10 min at
the indicated temperatures. Dimers and monomers were electrophoresed in a 1% native agarose gel and probed with an HIV-1 riboprobe, as
described in Materials and Methods. (iii) Electrophoresis using a lower percentage of agarose gel (0.7%) further resolved the slow-migrating
genomic RNAs into doublets. Stars indicate the location of the slow-migrating dimers.
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sociating into monomeric RNA at 48°C (Fig. 2ii) (13). In
contrast, the immature RNA dimers in PR virions migrated
with slightly less mobility a more diffused pattern and dissoci-
ated into monomer RNA at approximately 5 to 10°C below the
temperature at which WT RNA dissociated. However,
genomic RNA isolated from mutant virion particles that have
reduced levels of Gag-Pro-Pol [such as GF and GF PR(-)] or
that lack Gag-Pro-Pol (i.e., GUAA) migrated in a 1% agarose
gel with mobilities that are distinct from those for both the WT
mature and PR immature RNA dimers (Fig. 2ii). These mu-
tant RNA dimers also exhibited stability lower than that of WT
genomic RNA but comparable to that of PR genomic RNA.
Interestingly, it was noted that the slower-running RNA bands,
observed in the genomic RNA, derived from GF, GF PR(-),
and GUAA virions were also detected in small amounts within
the WT genomic RNA samples. Electrophoresis using a gel
with a lower percentage of agarose (0.7%) further resolved the
slow-migrating genomic RNAs into doublets (Fig. 2ii). Differ-
ences in the migration mobilities observed for these RNAs by
using 1 and 0.7% agarose may, in part, be due to variations in
resistance of agarose gels. The higher-migrating RNA band
within the doublet appeared to be present in small amounts in
the unheated PR sample (Fig. 2ii). The proportion of this
slow-migrating genomic RNA was, however, inversely corre-
lated with the presence of Gag-Pro-Pol in these mutant virion
particles.
The slow RNA dimer migration of Gag-derived virions is not
due to cellular or viral protein contamination. No detectable
levels of viral proteins were present in the RNA samples as
determined by Western blot analysis (data not shown). Addi-
tional proteinase K treatment of the GUAA-derived genomic
RNA was used to rule out the presence of a protein-RNA
aggregation within the GUAA RNA preparations as the cause
of their low electrophoretic mobility (Fig. 3i). RNA dimeriza-
tion analysis of samples before and after extended proteinase
K treatment showed no differences in migration or stability
among the Gag-derived genomic RNAs. In addition, the more
sensitive procedure of [35S]Met-Cys metabolic labeling was
employed. The genomic virion RNA was prepared from an
equivalent of approximately 13 g of labeled HIV-1 proteins,
FIG. 3. Metabolic labeling of virion proteins and electrophoretic analysis of proteinase K (PK)-treated genomic RNAs. (i) WT, GUAA, and
PK-treated GUAA RNA, isolated as described in Materials and Methods, was treated at the indicated temperatures for RNA dimerization analysis.
The star indicates the location of the slow-migrating dimers. (ii) Twofold dilutions of equal amounts of 35S-labeled virion proteins and genomic
RNA were loaded in a nitrocellulose (Hybond N) membrane. Results were visualized by autoradiography.
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as measured by the Lowry assay. While 35S labeling routinely
yielded approximately 124,800 cpm/g of protein, no radioac-
tive proteins were detected in the genomic RNA samples (Fig.
3ii). The phosphorimager used for the monitoring the 35S
radioactivity present in HIV-1 proteins has a detection limit of
as low as 1 ng of labeled protein. Thus, protein contamination
is not responsible for the slow migration of the Gag-derived
genomic RNA (GUAA).
Proteolytic processing of Gag alone is sufficient for genomic
RNA dimer stability. As RNA rearrangement in a dimeric
conformation with optimal stability occurs spontaneously with
or immediately after Gag processing by PR, we attempted to
determine the role of the Gag proteolysis by PR in RNA dimer
maturation, in the absence of Gag-Pro-Pol. We introduced an
active PR into the GUAA construct to generate PRUAA, which
produces VLPs with mature Gag proteins without RT and IN
(Fig. 4i). The genomic RNA extracted from the PRUAA viral
particles showed stability similar to (and sometime better than)
that of the WT genomic RNA (Fig. 4i). However, the migra-
tion pattern of these RNAs in 1% agarose gel was not com-
pletely restored to that of the WT, with a high-molecular-
weight band that often appeared as a doublet (Fig. 4ii). The
phenotype of these PRUAA RNA dimers resembled one rep-
resentative of an intermediate state between the GUAA and
WT RNA genome. These results suggest that the proteolytic
processing of Gag alone in VLPs is sufficient for genomic RNA
dimer stability but not for restoring WT RNA dimer confor-
mation.
Proteolytic processing of HIV-1 Gag alone is not sufficient
for the maturation of the virion core. Consistent with previous
reports (21), both immature and mature virions were detected
in the WT preparations by electron microscopy (EM) analysis
(Fig. 5d and e). However, only immature virions were detected
within the PR and GUAA preparations (Fig. 5a and b). Im-
mature particles were round or ovoid in shape and bound by
two outer concentric layers (Fig. 5a to d). These particles
measured about 90 to 110 nm in diameter. The distance be-
tween the two outer layers was about 10 nm. PRUAA prepara-
tions contained particles with cone-shaped aberrant cores (Fig.
5f to h) and immature virions resembling the PR-defective
particles (Fig. 5c). In longitudinal sections of the WT viral
particles, the central core structure extended along the particle
FIG. 4. Efficient Gag processing by PR of Gag and its effect on RNA dimer formation and stability. (i) Intracellular viral protein levels and total
virion protein levels were standardized by EGFP and dot blot analysis, respectively (data not shown). Transfected cell lysates and purified virions
(see Materials and Methods) were resolved by 10% Tris-glycine SDS-PAGE. Resolved proteins were probed with pooled sera from HIV-1-infected
individuals as described in Materials and Methods. Lanes 1, WT cellular viral protein (cell) and virion protein (virion) profiles; lanes 2, cellular
viral protein and virion protein profiles of GUAA; lanes 3, cellular viral proteins and virion protein profiles of PRUAA. (ii) To examine RNA dimer
formation and stability, genomic RNA isolated from the WT and GUAA and PRUAA mutants was heated to the indicated temperatures and
electrophoresed in a 1% agarose gel, transferred, and probed with a HIV-1 riboprobe. Results were visualized by autoradiography. The star
indicates the location of the slow-migrating dimers.
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and frequently contained dark-staining cone-shaped core ma-
terial (Fig. 5e). Although similar to WT virions, the PRUAA
virions had a cone-shaped core structure (Fig. 5f to h); the
electron-dense dark-staining bodies were absent from the in-
side of the cores but could occasionally be found adjacent to
the empty core (Fig. 5g and h). Particles in both WT and
PRUAA preparations were round or oval and measured about
90 to 95 nm in diameter.
Supplementation of the RT-IN complex in trans restores the
conformation of HIV-1 RNA dimers and the virion core. We
cotransfected the PRUAA plasmid with Vpr-RT, Vpr-IN, or
Vpr-RT-IN constructs to express RT and IN individually or
simultaneously as a fusion protein (RT-IN). Lysates of cells
cotransfected with PRUAA and the Vpr-RT expression vectors
showed a band with a molecular mass of approximately 81
kDa, consistent with the molecular mass of Vpr-RT, as well as
a band with a molecular mass 66 kDa (RT) at the same posi-
tion as WT RT (Fig. 6i, cell, lane 3). Cotransfection with
PRUAA and Vpr-IN resulted in a band of approximately 47
kDa, which is consistent with the molecular mass of the Vpr-IN
fusion (Fig. 6i, cell, lane 4). Lysates of cells cotransfected with
the PRUAA and Vpr-RT-IN expression vectors showed overall
intracellular protein patterns similar to that of the WT and an
additional band (Vpr-RT-IN) of approximately 120 kDa (Fig.
6i, cell, lane 5). The immunoblotting of the purified virions
showed efficient processing and virion packaging of RT, IN,
and RT-IN (Fig. 6i, virion, lanes 4 to 6, respectively). A small
amount of unprocessed Vpr-RT complex previously observed
in the cellular lysates was also detected in the virions packaging
RT in trans (Fig. 6i, virion, lane 4). These results are consistent
with the initial report that showed successful packaging and
proteolytic processing of RT, IN, and RT-IN in the virions
when provided in trans as part of a Vpr fusion (45).
Genomic RNA isolated from virions showing incorporation of
Vpr-RT, Vpr-IN, and Vpr-RT-IN fusion proteins (Fig. 6ii) were
assayed for RNA dimer formation and stability. Provision of RT
and IN separately as Vpr fusion proteins did not rescue the
dimeric conformation of the genomic RNA in these mutant par-
ticles. However, the genomic RNA isolated from PRUAA/Vpr-
RT-IN particles displayed dimer stability and electrophoretic mo-
bility similar to that of the dimeric RNA in WT HIV-1 (Fig. 6ii).
Furthermore, the empty cone-shaped core in PRUAA was also
restored to WT upon the supplementation of Vpr-RT-IN fusion
protein (Fig. 6iii), demonstrating the importance of the HIV-1
Pol protein in the complete maturation of the virion RNA dimers
and the formation of the mature virion core.
DISCUSSION
We have identified a high-molecular-weight, unstable form
of viral genomic RNA, which may be an intermediate confor-
mation of the RNA dimers that occurs prior to the full matu-
ration of the dimeric RNA genome. We further show here that
Gag proteolysis stabilizes RNA dimers but fails to facilitate the
complete rearrangement of genomic RNA into the dimeric
form found in the WT. Our results also substantiate current
evidence that RNA packaging is distinct from RNA dimeriza-
tion and highlight the importance of Gag-Pro-Pol in RNA
dimer maturation during HIV-1 assembly. The provision of RT
and IN in trans as a Vpr-RT-IN fusion protein restores the
FIG. 5. EM analysis of the mutant viral particles. Thin-section electron micrographs of the main HIV-1 particle types detected in the three
mutant preparations and the control preparation. (a) Immature-particle PR preparation; (b) immature-particle GUAA preparation; (c) immature-
particle PRUAA preparation; (d) immature-particle WT control preparation; (e) mature-particle WT control preparation; (f to h) mature-particle
PRUAA preparations. The core typically appeared empty (open arrows) although a dark-staining body was sometimes seen adjacent to the core
(solid arrows). Bar 	 100 nm (same scale for all panels).
VOL. 76, 2002 RNA MATURATION IN HIV-1 4337
FIG. 6. Supplementation with RT, IN, and RT-IN in trans: cellular expression and virion incorporation and processing. Provision of RT-IN in
trans restores virion RNA conformation and core condensation. (i) Similar amounts of intracellular and virion proteins were resolved by 10%
Tris-glycine SDS-PAGE and gel electrophoresis. Transferred proteins were probed with HIV-1 sera to assess the presence of Vpr-RT, Vpr-IN,
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conformation of the genomic RNA dimers to that found in WT
virions and also restores the electron-dense cone-shaped core.
Data presented here reconfirm the strong correlation between
RNA dimer maturation and core condensation that we have
reported recently (39).
The process of RNA packaging and dimerization is directly
linked to Gag, whether in its precursor form as the Gag
polyprotein or following processing by viral PR to its constit-
uent proteins (2, 29). Extensive studies have shown that spe-
cific and nonspecific binding of the basic residues of Gag to the
HIV-1 RNA genome ensures proper packaging of the viral
genomic RNA within the virion. The N terminus of NC, in-
cluding some specific basic residues and its zinc finger(s), has
a distinctive role in RNA dimerization and packaging in Molo-
ney murine leukemia virus, Rous sarcoma virus, and HIV-1 (3,
4, 7, 9, 16, 17, 39). The finding that PR-defective viral particles
encapsidate dimeric RNA (13) demonstrates that Gag is suf-
ficient for the initiation of the RNA dimerization process.
However, the in vivo role of the Gag precursor alone in dimer
maturation has not been described. While Gag-derived parti-
cles packaged normal levels of viral genomic RNA, the dimeric
RNA is less stable than that of the WT and migrates more
slowly in a native gel. The lower stability of these RNA dimers
is consistent with the low stability of RNA dimers in PR-
defective immature HIV-1 described by Fu et al. (13). The
altered mobility of virion genomic RNAs in GUAA is clearly
distinct from that of virion RNA dimers found in WT mature
and PR-defective immature particles. To our knowledge, the
genomic RNA complexes found in GUAA have not previously
been described.
Our analysis ruled out viral protein contamination as the
cause of this altered mobility. However, several groups have
shown that the in vitro assembly of HIV-1 and other retrovi-
ruses can be facilitated by nonviral RNAs (5, 6, 33). Therefore,
it is possible that RNAs of cellular origin could potentially
form aggregates with the viral genomic RNA, thus altering the
conformation of the packaged dimeric RNA within these par-
ticles. Muriaux et al. have recently demonstrated that virion
packaging of cellular RNA can occur in viral RNA packaging-
deficient Moloney murine leukemia virus, thus compensating
for the lack of nascent virion RNA (35). Yet, we found no
major differences in viral genomic RNA packaging between
GUAA and WT particles; consequently, it appears that the
altered mobility of viral RNA species found in the Gag-derived
particles is due to genomic RNA that has a conformation
different from that of WT RNA. Further analysis of these
RNA dimers showed the presence of some dimers resembling
the WT RNA dimers and others that migrate more slowly than
WT dimers on a lower-percentage nondenaturing gel. Laugh-
rea and Jette have previously shown that two forms of RNA
dimers (tightly and loosely associated) can be generated via in
vitro RNA dimerization (26). While it is difficult to compare
the two in vitro forms of RNA dimers described by Laughrea
and Jette with the distinct forms of RNA dimers shown in this
study, it is possible that our respective studies refer to RNA
dimers with similar conformations.
Introduction of an active PR to the Gag-derived particles
(PRUAA) restored dimer stability. This is consistent with pre-
vious reports (10, 11, 34, 38, 39) which show that genomic
RNA dimer stability is under the control of mature NC. How-
ever, in our study, while immature dimers were formed in the
complete absence of the Pol protein and the active PR restored
dimeric RNA stability to WT levels, Gag proteolysis did not
correct the RNA conformation. This finding suggests that re-
gions in the Pol protein other than PR are also important for
coordinating the arrangement of viral genomic RNA.
Several studies have collectively demonstrated that Gag-
Pro-Pol synthesis and its incorporation within the viral particle
are critical for HIV-1 function or morphogenesis (23, 25, 37,
38). The 20:1 ratio of Gag to Gag-Pro-Pol production supports
the greater requirement for structural proteins over enzymatic
proteins during viral assembly, and maintenance of the ratio is
critical for viral function (23, 38). It has been shown that
Gag-Pro-Pol interacts with Gag during virus particle formation
(36, 40). Specific viral functions linked to Gag-Pro-Pol synthe-
sis and incorporation include proteolytic processing, reverse
transcription, integration, and tRNA3
Lys packaging (30–32). In
a recent study we reported that efficient incorporation of Gag-
Pro-Pol in trans supports the enzymatic function of HIV-1 (20).
Here, to assess the role of Gag-Pro-Pol-derived enzymes RT
and IN in RNA dimer maturation, independently of the Gag-
Pro-Pol precursor, we provided these proteins in trans during
cotransfection with PRUAA either individually as Vpr-RT and
Vpr-IN or as fusion protein Vpr-RT-IN (45). While the pack-
aging of either RT or IN did not fully restore RNA dimer
conformation, the packaging of the RT-IN fusion protein gen-
erated RNA dimers that are similar to those of WT HIV-1. By
showing that the genomic RNA structure of the RT-IN-sup-
plemented virions closely resembles that of the WT virus, our
data suggest a specific role for RT-IN in RNA rearrangement
during viral assembly and viral particle maturation.
It has been proposed that RT interacts with NC in order to
form the RNP complex and that a direct RT-NC interaction is
required for reverse transcription in vivo (44). It is possible
that RT and NC interact at different stages of viral assembly,
contributing not only to the formation of the RNP complex but
also to the maturation of the virion core. A role for RT and IN
in virion core formation is supported in our study by the results
of EM analysis of the Gag-derived particles. While Gag-de-
rived virions appeared as empty immature particles, the pro-
cessed Gag particles (PRUAA) were detected as aberrant viri-
ons with empty but cone-shaped cores. As expected, provision
of RT-IN as part of Vpr fusion resulted in the formation of
electron-dense cone-shaped cores. Our data underline the im-
portance of Gag-Pro-Pol in virion morphogenesis by showing
and Vpr-RT-IN in transfected cells and the levels of RT and IN packaged within the virions. (ii) The effect of supplementation with RT, IN, and
RT-IN within PRUAA on conformational changes of genomic RNA was examined by melting curve and electrophoretic analyses of WT and mutant
RNAs. Samples were electrophoresed in 1% native agarose gel and probed with an HIV-1 riboprobe as described in Materials and Methods. (iii)
Virions packaging RT-IN provided in trans as a Vpr fusion protein show a morphology similar to that of the WT (condensed, electron-dense cores)
and distinct features, unlike virions deficient in RT and IN (empty cone-shaped cores).
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that Gag-Pro-Pol and in particular RT-IN are critical for the
formation of the infectious virion core.
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